Onset of cardiac iron loading in pediatric patients with thalassemia major

Haematologica

Volumn 93, Issue 6, 2008, Pages 917-920

  Wood, John C ^a   Origa, Raffaella ^b   Agus, Annalisa ^b   Matta, Gildo ^c   Coates, Thomas D ^a   Galanello, Renzo ^b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c San Michele Hospital   (Italy)

Author keywords

Children; Heart; Iron overload; MRI; Thalassemia major

Indexed keywords

FERRITIN; IRON;

ADOLESCENT; ADULT; ARTICLE; CHELATION THERAPY; CHILD; HEART; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK FACTOR; SCREENING TEST; THALASSEMIA MAJOR; TRANSFUSION;

ADOLESCENT; ADULT; AGE FACTORS; BETA-THALASSEMIA; CHILD; COHORT STUDIES; HUMANS; IRON; IRON CHELATING AGENTS; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING; PILOT PROJECTS; REGRESSION ANALYSIS; RISK FACTORS; ROC CURVE;

EID: 44949259826     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12513     Document Type: Article

References (15)

1. Buja LM, Roberts WC. Iron in the heart. Etiology and clinical significance. Am J Med 1971;51:209-21.
2. Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994;331:567-73.
3. Wood JC, Tyszka JM, Ghugre N, Carson S, Nelson MD, Coates TD. Myocardial iron loading in transfusion-dependent thalassemia and sickle-cell disease. Blood 2004;103:1934-6.
4. Wood JC, Enriquez C, Powell A, Ghugre N, Nelson MD, Polzin J, et al. Single-echo versus multiple echo cardiac T2* estimates for cardiac iron estimation in iron overload. J Cardiovasc Magn Reson 2005;7:97.
5. Ghugre NR, Enriquez CM, Gonzalez I, Nelson MD Jr, Coates TD, Wood JC. MRI detects myocardial iron in the human heart. Magn Reson Med 2006;56:681-6.
6. Ghugre NR, Enriquez CM, Coates TD, Nelson MD Jr, Wood JC. Improved R2* measurements in myocardial iron overload. J Magn Reson Imaging 2006;23:9-16.
7. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005;106:1460-5.
8. Aessopos A, Fragodimitri C, Karabatsos F, Hatziliami A, Yousef J, Giakoumis A, et al. Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia. Haematologica 2007;92:131-2.
9. Tanner MA, Galanello R, Dessi C, Westwood MA, Smith GC, Nair SV, et al. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson 2006;8:543-7.
10. Tanner MA, Westwood M, Galanello R, Pennell DJ. Baseline findings of a CMR driven randomized controlled trial of iron chelation therapy in thalassemia major. JCMR 2005;7:31-2.
11. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-9.
12. Jensen PD, Jensen FT, Christensen T, Eiskjaer H, Baandrup U, Nielsen JL. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood 2003;101:4632-9.
13. Angelucci E, Brittenham GM, McLaren CE, Ripalti M, Baronciani D, Giardini C, et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 2000;343:327-31.
14. Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B. Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol 2000;110:971-7.
15. Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004;89:1187-93.